Corbus Pharmaceuticals (NASDAQ:CRBP) Now Covered by Analysts at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a research report sent to investors on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, Oppenheimer reissued an outperform rating and set a $22.00 price objective on shares of Corbus Pharmaceuticals in a report on Wednesday, August […]
Oppenheimer Reaffirms Outperform Rating for Corbus Pharmaceuticals (NASDAQ:CRBP) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Corbus Pharmaceuticals (NASDAQ:CRBP) Shares Cross Below 50-Day Moving Average of $8 99 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Get Rating) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. CRBP has been the topic of several other research reports. Oppenheimer raised Corbus Pharmaceuticals from a “market perform” rating to an […]